Precision Diagnosis, Classification & Advanced Treatment

Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Order Anthology Diagnostics‘ Hematology Expression/Fusion Profile The Anthology Diagnostics Hematology Expression/Fusion test provides actionable information for: 1) Determining Fusion and classification (Ph-Positive or Ph-Like) Acute lymphoblastic leukemia (ALL) is a heterogeneous disease with genomic alterations dominated by structural chromosomal abnormalities, particularly translocations. Most of the reported chromosomal translocations in ALL lead to the expression of […]

Read More

Hackensack Meridian Health Launches Anthology Diagnostics Laboratories for State-of-the-Art Lab Genomic Profiling of Cancers

Hackensack Meridian Health Launches Anthology Diagnostics Laboratories for State-of-the-Art Lab Genomic Profiling of Cancers

EDISON, N.J. AND IRVINE, C.A. (March 16, 2021) — Hackensack Meridian Health and Genomic Testing Cooperative (GTC) in Irvine, California, have teamed up to establish the first-of-its-kind genomic profiling laboratory called Anthology Diagnostics, to generate more personalized, precise, and real-time insights for cancer patients, oncologists and hospitals.   The reference laboratory located at Hackensack Meridian JFK University Medical […]

Read More

Diffuse Large B-Cell Lymphoma (DLBCL)

Lymphoma

Order Anthology Diagnostics` Hematology Expression/Fusion Profile Anthology Diagnostics Hematology Expression/Fusion Profiling provides highly informative and actionable data for patients with DLBCL as follows: 1) B-cell Markers: This assay provides data on the expression of markers specific to B-cell. It will report the levels of expression of B-cell markers, including CD19, CD79A, CD79B, PAX5, CD22, and […]

Read More